Filter posts

Tekmira CEO Discusses Ebola Therapy Development at 2014 BIO Investor Forum

Today at the 13th Annual BIO Investor Forum, Tekmira CEO Dr. Mark Murray participated in a …

Gates Foundation and Grand Challenge Partners Announce New Investments in Breakthrough Science

At an event in Seattle today, the Bill & Melinda Gates Foundation and a group …

New PhRMA report: Nearly 800 Cancer Medicines in Development

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) shows that biopharma …

Washington Post: Why Extremely Expensive Drugs Are Often Worth the Cost

Jason Millman highlights a new study published in Health Affairs showing specialty drugs often provide …

Health Affairs: 5 Myths about Cancer Care in America

In the latest issue of Health Affairs, Dana Goldman of the University of Southern California …

Cancer drugs save and extend lives

This week, CBS aired a misleading segment on the cost of innovative cancer therapies. BIO …

5 Priorities for Reducing Infant Mortality

In the U.S., the number of babies who die in their first year of life …

New Treatments Needed for Obesity

ObesityWeek 2014, Nov. 2-7, in Boston Offers Opportunities to Learn & Connect Coauthored by The …

The Hill: In War on Cancer, Patients at Risk of Becoming Commoditized

Ted Okon, executive director of the Community Oncology Alliance, highlights the significant progress the medical …

DEA’s Prescription Drug Take Back Day is September 27

National Prescription Drug Take Back Day is tomorrow – Saturday, Sept. 27, 2014 – from …